首页 > 市场调查报告书 > 製药

循环系统

市场调查报告书

商品编码

1372869

洛沙坦市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按来源、形式、按应用、地区和竞争细分

Losartan Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Source, By Form, By Application, By Region and Competition

出版日期: 2023年10月03日 | 出版商:

TechSci Research | 英文 189 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2022 年全球氯沙坦市场价值为 16.4 亿美元，预计在预测期内将出现显着增长，预计到 2028 年复合年增长率 (CAGR) 为 4.89%。

氯沙坦是一种主要用于治疗高血压和特定心臟病的药物。它属于血管张力素 II 受体阻断剂 (ARB) 药物类别。氯沙坦透过舒张血管发挥作用，有效降低血压并促进血液循环。

氯沙坦的医药市场包括製药公司生产、分销和销售氯沙坦片剂或胶囊。此外，该市场可能包括氯沙坦的各种仿製药，随着品牌药物的专利到期而上市。氯沙坦不仅用于治疗高血压，还可以用于治疗心臟衰竭等疾病，并降低高血压和心臟扩大患者中风的风险。

市场概况
预测期	2024-2028
2022 年市场规模	16.4亿美元
2028 年市场规模	21.9亿美元
2023-2028 年复合年增长率	4.89%
成长最快的细分市场	合约製造组织
最大的市场	北美洲

主要市场驱动因素

高血压盛行率不断上升

高血压（高血压）是全世界常见的健康状况。随着全球人口老化以及不良饮食和久坐行为等生活方式因素的持续存在，高血压的盛行率趋于增加。这推动了对氯沙坦等抗高血压药物的需求。现代久坐的生活方式，加上高盐和加工食品的饮食，会导致血压水平升高。不良的饮食选择、缺乏运动和肥胖是已知的高血压危险因子。随着这些生活习惯的持续存在，越来越多的人被诊断出患有高血压，导致对氯沙坦等用于控制和管理病情的药物的需求增加。

老年人口增加

老年人口的增加是氯沙坦需求增加的重要推动因素，氯沙坦是一种用于治疗高血压和某些心臟疾病的药物。这种人口结构的变化正在重塑医疗保健的优先事项，并加剧了对高血压等与年龄相关的健康问题的有效治疗的需求。随着个体年龄的增长，患高血压的风险大大增加。由于血管弹性和荷尔蒙调节的变化，血压往往会随着年龄的增长而升高。因此，不断增长的老年人口导致高血压盛行率升高，需要氯沙坦等药物干预措施来维持最佳血压水平。

氯沙坦特别适合老年人。其作为血管紧张素 II 受体阻断剂 (ARB) 的作用机制使其能够放鬆血管、减少动脉僵硬度并有效降低血压，所有这些对于控制老年人高血压至关重要。此外，氯沙坦的安全性和相对轻微的副作用使其成为可能需要多种药物来治疗各种与年龄相关的疾病的老年人的首选。

医疗保健服务的改善以及对与不受控制的高血压相关的健康风险的认识的提高，使得老年人群能够得到更早的诊断和治疗。随着医疗保健提供者强调血压控制的重要性，氯沙坦已成为老年人高血压医疗管理的主要药物。预计未来几年人口老化趋势将持续，65 岁以上人口比例不断增加。因此，随着医疗保健系统满足该族群的独特医疗保健需求，对氯沙坦和其他抗高血压药物的需求预计将上升。氯沙坦在维持老年人心血管健康和生活品质方面的作用凸显了其在满足老龄化世界的医疗保健需求方面的重要性。

提高临床疗效

氯沙坦和其他血管张力素 II 受体阻断剂 (ARB) 已证明其在降低血压和降低心血管事件风险方面的有效性。正面的临床结果和良好的安全性可以促使医疗保健提供者开出氯沙坦处方。氯沙坦不断提高的临床疗效是其在医疗保健领域需求不断增长的关键驱动力。氯沙坦是一种血管紧张素 II 受体阻断剂 (ARB)，因其在控制高血压和某些心臟病方面的有效性而受到关注，使其成为医疗保健提供者和患者的首选。

此外，氯沙坦已显示出降低高血压患者心血管事件风险的功效。众所周知，它可以透过减少心臟压力和改善血流量对心臟健康产生积极影响。它对心血管系统的保护作用使其成为预防心臟病、中风和其他心血管併发症的宝贵工具，这对医疗保健提供者和患者来说都是一个重要的考虑因素。氯沙坦在降低血压、降低心血管风险方面不断增强的临床疗效及其良好的耐受性使其成为医疗保健提供者和患者的首选。这项临床成功推动了氯沙坦治疗高血压和相关心血管疾病的需求不断增长。

专利到期和仿製药竞争

氯沙坦品牌药物的专利到期后，仿製药可以进入市场。仿製药竞争通常会导致药品价格下降，使更广泛的人群更容易获得药物。氯沙坦等品牌药物的专利到期导致仿製药的推出，从而显着增加了对氯沙坦的需求。仿製药通常比品牌药便宜。随着氯沙坦的专利到期，仿製药製造商能够以较低的成本生产和销售其版本的药物。这种负担能力使更多的患者可以使用氯沙坦，从而增加了那些以前可能因品牌产品的成本而望而却步的人的需求。

随着氯沙坦仿製药的出现，更多的医疗保健提供者可能倾向于将其作为患者的经济有效的选择。氯沙坦的使用范围扩大使更多的人受益于其抗高血压特性，从而增加了需求。随着仿製药氯沙坦在市场上变得更加普遍和可信，患者和医疗保健专业人员都更加意识到其可用性和功效。这种认识的提高导致了更多的处方和对氯沙坦的更高的需求。

主要市场挑战

副作用和耐受性

氯沙坦的副作用和耐受性可能是阻碍某些人对其需求和使用的重要因素。虽然许多患者通常对氯沙坦的耐受性良好，但有些患者可能会出现副作用，导致停药或不愿使用该药物。耐受性也因人而异。有些患者可能发现氯沙坦比其他抗高血压药物的耐受性更好，而其他患者可能有不同的反应。个体因素，例如年龄、潜在疾病和合併用药，可能会影响一个人对氯沙坦的耐受程度。虽然氯沙坦是一种有效的抗高血压药物，但其副作用和耐受性问题可能会阻碍某些人对其的需求和使用。患者教育、与医疗保健提供者的开放沟通以及个人化治疗计划对于解决这些问题并确保患者接受适当的高血压治疗同时最大限度地减少副作用至关重要。

替代药物

有多种类型的抗高血压药物可供选择，医疗保健提供者可能会根据患者的个别特征和偏好开出替代药物。合併症、禁忌症和患者反应等因素可能会影响药物的选择，在某些情况下可能会减少对氯沙坦的需求。患者对药物的偏好和信念可能会影响他们服用氯沙坦或其他药物的意愿。有些患者可能更喜欢自然疗法、整体疗法或替代疗法而不是药物干预，从而减少了对氯沙坦的需求。医疗保健差异，包括获得医疗保健服务和药物的机会不平等，可能会限制服务不足的人口对氯沙坦的需求。医疗保健取得方面的不平等可能会阻碍个人接受适当的诊断和治疗。

有特定医疗状况或禁忌症的患者可能不适合服用氯沙坦。例如，患有某些肾臟疾病或对氯沙坦过敏的人可能会被开出替代药物。在某些情况下，医疗保健提供者会开出包含不只一种抗高血压药物的联合疗法。这些组合可以包括不同类别的药物或同一类别内的多种药物。联合治疗的选择取决于患者独特的医疗需求和最佳血压控制的愿望。

主要市场趋势

远距医疗和远端监控

远距医疗和远端监控技术的采用扩大了医疗保健服务的范围。这些技术使医疗保健提供者能够远端监测患者的血压并根据需要调整治疗计划，从而可能增加对氯沙坦等药物的需求。远距医疗允许患者远距咨询医疗保健提供者，消除地理障碍，使个人更容易获得及时的医疗照护。这种增强的可及性可以导致更频繁的血压监测和更好的药物管理。患者可以在舒适的家中与医疗保健专业人员讨论他们的治疗计划，包括氯沙坦的使用。

远端监测设备，例如家用血压计和穿戴式设备，使患者能够持续追踪自己的血压水平。这些设备可以直接将资料传输给医疗保健提供者，以便在必要时进行即时监控和调整治疗计划。透过持续监测可以更准确地评估氯沙坦的有效性。

个人化医疗

医疗保健技术和基因研究的进步正在带来更个人化的治疗方法。考虑个人基因组成和独特健康特征的客製化治疗计划可能会增加对氯沙坦等药物的需求，这可以成为个人化高血压管理策略的一部分。个人化医疗通常从基因分析开始。透过分析个人的基因组成，医疗保健提供者可以识别影响其对药物反应的基因变异。对于氯沙坦，基因检测可以帮助确定患者是否更有可能对该药物产生良好反应，或者替代疗法是否可能更合适。这种精确的方法确保将氯沙坦开给最有可能从中受益的人，从而增加了合适候选人的需求。

个人化医疗允许根据遗传和个别患者资料微调药物剂量。对于氯沙坦来说，这意味着医疗保健提供者可以调整剂量，以实现每位患者的最佳血压控制。避免过度或用药不足可以改善患者的治疗效果并减少潜在的副作用，从而提高患者的满意度和对氯沙坦的需求。

细分市场洞察

形成洞察

根据形式，市场分为片剂和粉末。片剂形式的氯沙坦的需求高于其他形式（例如粉剂）的需求。片剂易于操作和吞嚥，使其成为大多数患者（包括老年人和吞嚥困难患者）的便捷选择。片剂经过预先测量并提供标准化剂量，确保准确且一致的用药。氯沙坦片剂通常采用泡罩包装或瓶子包装，以便于安全储存和运输。患者和医疗保健提供者通常更熟悉片剂药物，这有助于其受欢迎。

应用洞察

根据应用领域，市场分为高血压、中风、糖尿病肾病变等。高血压细分市场占据主导地位，因为氯沙坦主要用于治疗高血压（俗称高血压）。高血压是一个普遍存在的健康问题，影响着全球很大一部分人口。据估计，全世界有超过十亿人患有高血压。这种高盛行率确保了对氯沙坦等抗高血压药物的持续和大量需求。近年来，人们一致努力提高人们对高血压的认识并推广定期血压监测。因此，越来越多的人被诊断出患有高血压，导致对有效治疗的需求增加。随着年龄的增长，高血压往往变得更加普遍。随着全球人口老化，越来越多的人面临高血压的风险，进一步推动了对抗高血压药物的需求。

区域洞察

北美，包括美国和加拿大，对氯沙坦等抗高血压药物的需求量大。该地区人口老化严重，高血压是常见的健康问题。人们对心血管健康的认识的提高和获得医疗保健服务的机会的增加导致了对这些药物的强劲需求。美国和加拿大拥有完善的医疗保健系统和基础设施。获得医疗保健服务（包括定期检查和诊断测试）的情况相对普遍。这有助于高血压的诊断和管理，并增加了对抗高血压药物的需求。北美非常重视健康意识和预防。医疗保健组织、政府机构和非营利组织所进行的教育活动和措施提高了人们对包括高血压在内的心血管危险因子的认识。这种意识的提高鼓励个人寻求医疗护理并遵守规定的治疗计划，包括使用氯沙坦等药物。

商业概览
服务内容
最近的发展
主要人员
SWOT分析
- Merck & Co. Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi SA
- Novartis International AG
- Dr. Reddy's Laboratories Ltd.
- Sun Pharmaceuticals Industries Ltd.
- Aurobindo Pharma Ltd.
- Torrent Pharmaceutical Ltd.
- Lupin Ltd.

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录

Product Code: 7269

The Global Losartan Market, valued at USD 1.64 Billion in 2022, is poised for remarkable growth in the forecast period, with an anticipated Compound Annual Growth Rate (CAGR) of 4.89% through 2028.

Losartan is a medication primarily prescribed for the treatment of high blood pressure (hypertension) and specific heart conditions. It falls under the category of drugs known as angiotensin II receptor blockers (ARBs). Losartan operates by relaxing blood vessels, effectively reducing blood pressure and enhancing blood circulation.

The pharmaceutical market for Losartan encompasses the production, distribution, and sale of Losartan tablets or capsules by pharmaceutical companies. Additionally, this market may include various generic versions of Losartan that become available as the patent for the brand-name medication expires. Losartan is not only used to manage hypertension but may also be employed for treating conditions like heart failure and reducing the risk of stroke in individuals with hypertension and an enlarged heart.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 1.64 Billion
Market Size 2028	USD 2.19 Billion
CAGR 2023-2028	4.89%
Fastest Growing Segment	Contract Manufacturing Organizations
Largest Market	North America

Key Market Drivers

Growing Prevalence of Hypertension

High blood pressure (hypertension) is a common health condition worldwide. As the global population ages and lifestyle factors such as poor diet and sedentary behavior continue, the prevalence of hypertension tends to increase. This drives the demand for antihypertensive medications like Losartan. Modern sedentary lifestyles, coupled with diets high in salt and processed foods, contribute to rising blood pressure levels. Poor dietary choices, lack of exercise, and obesity are known risk factors for hypertension. As these lifestyle habits persist, more people are diagnosed with high blood pressure, leading to an increased demand for medications like Losartan to control and manage their condition.

Increased awareness and healthcare accessibility have led to earlier diagnosis and treatment of hypertension. Health campaigns and routine health check-ups have heightened awareness of the risks associated with uncontrolled blood pressure, prompting individuals to seek medical intervention. Losartan's efficacy in reducing blood pressure and its tolerability have made it a preferred choice among healthcare providers, further driving its demand. The availability of generic versions of Losartan has made hypertension management more affordable for patients, increasing its accessibility to a broader population. This affordability factor has a significant impact on the demand for Losartan, especially in regions with limited healthcare resources.

Rising Geriatric Population

The rising geriatric population is a significant driver of the increasing demand for Losartan, a medication used to manage hypertension and certain heart conditions. This demographic shift is reshaping healthcare priorities and intensifying the need for effective treatments for age-related health issues, such as high blood pressure. As individuals age, the risk of developing hypertension rises substantially. Blood pressure tends to increase with age due to changes in blood vessel elasticity and hormonal regulation. Consequently, a growing elderly population translates to a higher prevalence of hypertension, necessitating pharmaceutical interventions like Losartan to maintain optimal blood pressure levels.

Losartan is particularly well-suited for older adults. Its mechanism of action as an angiotensin II receptor blocker (ARB) allows it to relax blood vessels, reduce arterial stiffness, and lower blood pressure effectively, all of which are crucial in managing hypertension in the elderly. Additionally, Losartan's safety profile and relatively mild side effects make it a preferred choice for older individuals who may have multiple medications to manage various age-related conditions.

Improved healthcare access and increased awareness of the health risks associated with uncontrolled hypertension have led to earlier diagnosis and treatment in the elderly population. With healthcare providers emphasizing the importance of blood pressure control, Losartan has become a staple in the medical management of hypertension among older adults. The aging population trend is expected to continue in the coming years, with a growing proportion of people over the age of 65. Consequently, the demand for Losartan and other antihypertensive medications is poised to rise as healthcare systems address the unique healthcare needs of this demographic. Losartan's role in maintaining cardiovascular health and quality of life in the elderly population underscores its significance in meeting the healthcare demands of an aging world.

Increasing Clinical Efficacy

Losartan and other angiotensin II receptor blockers (ARBs) have demonstrated their effectiveness in lowering blood pressure and reducing the risk of cardiovascular events. Positive clinical outcomes and a good safety profile can drive healthcare providers to prescribe Losartan. The increasing clinical efficacy of Losartan is a key driver behind its growing demand in the healthcare sector. Losartan, an angiotensin II receptor blocker (ARB), has gained prominence due to its effectiveness in managing hypertension and certain heart conditions, making it a preferred choice for both healthcare providers and patients.

Furthermore, Losartan has shown efficacy in reducing the risk of cardiovascular events in hypertensive individuals. It is known to have a positive impact on cardiac health by decreasing the strain on the heart and improving blood flow. Its protective effects on the cardiovascular system make it a valuable tool in the prevention of heart attacks, strokes, and other cardiovascular complications, which is a critical consideration for healthcare providers and patients alike. The increasing clinical efficacy of Losartan in lowering blood pressure, reducing cardiovascular risks, and its favorable tolerability profile have made it a preferred choice for healthcare providers and patients. This clinical success is a driving force behind the growing demand for Losartan in the treatment of hypertension and related cardiovascular conditions.

Patent Expiration and Generic Competition

The expiration of patents for brand-name Losartan medications allows generic versions to enter the market. Generic competition often leads to lower drug prices, making the medication more accessible to a broader population. The expiration of patents for brand-name medications like Losartan has led to the introduction of generic versions, significantly increasing the demand for Losartan. Generic medications are typically more affordable than their brand-name counterparts. As Losartan's patent expired, generic manufacturers were able to produce and market their versions of the drug at a lower cost. This affordability makes Losartan accessible to a broader population of patients, increasing its demand among those who may have been previously deterred by the cost of the brand-name product.

With the availability of generic Losartan, more healthcare providers may be inclined to prescribe it as a cost-effective option for their patients. This expanded access to Losartan enables a larger number of individuals to benefit from its antihypertensive properties, thus increasing demand. As generic Losartan becomes more prevalent and trusted in the market, patients and healthcare professionals alike become more aware of its availability and efficacy. This increased awareness leads to more prescriptions and higher demand for Losartan.

Key Market Challenges

Side Effects and Tolerability

The side effects and tolerability of Losartan can be a significant factor hindering its demand and use among some individuals. While Losartan is generally well-tolerated by many patients, some may experience side effects that lead to discontinuation or reluctance to use the medication. Tolerability also varies from person to person. Some patients may find Losartan to be better tolerated than other antihypertensive medications, while others may have a different response. Individual factors, such as age, underlying medical conditions, and concomitant medications, can influence how well a person tolerates Losartan. While Losartan is an effective antihypertensive medication, its side effects and tolerability issues can hinder its demand and use among certain individuals. Patient education, open communication with healthcare providers, and personalized treatment plans are essential in addressing these concerns and ensuring that patients receive appropriate treatment for their hypertension while minimizing side effects.

Alternative Medications

There are several classes of antihypertensive medications available, and healthcare providers may prescribe alternative drugs based on individual patient characteristics and preferences. Factors such as comorbidities, contraindications, and patient response can influence the choice of medication, potentially reducing the demand for Losartan in some cases. Patient preferences and beliefs about medications can influence their willingness to take Losartan or other drugs. Some patients may prefer natural remedies, holistic approaches, or alternative therapies over pharmaceutical interventions, reducing the demand for Losartan. Healthcare disparities, including unequal access to healthcare services and medications, can limit the demand for Losartan among underserved populations. Inequities in healthcare access can prevent individuals from receiving appropriate diagnoses and treatments.

Patients with specific medical conditions or contraindications may not be suitable candidates for Losartan. For instance, individuals with certain kidney conditions or allergies to Losartan may be prescribed alternative medications. In some cases, healthcare providers prescribe combination therapies that include more than one type of antihypertensive medication. These combinations can include different classes of drugs or multiple drugs within the same class. The choice of combination therapy depends on the patient's unique medical needs and the desire for optimal blood pressure control.

Key Market Trends

Telehealth and Remote Monitoring

The adoption of telehealth and remote monitoring technologies has expanded access to healthcare services. These technologies allow healthcare providers to monitor patients' blood pressure remotely and adjust treatment plans as needed, potentially increasing the demand for medications like Losartan. Telehealth allows patients to consult with healthcare providers remotely, eliminating geographical barriers and making it easier for individuals to receive timely medical care. This enhanced accessibility can lead to more frequent monitoring of blood pressure and better medication management. Patients can discuss their treatment plans, including the use of Losartan, with healthcare professionals from the comfort of their homes.

Remote monitoring devices, such as home blood pressure monitors and wearable devices, enable patients to track their blood pressure levels consistently. These devices can transmit data directly to healthcare providers, allowing for real-time monitoring and adjustments to treatment plans when necessary. Losartan's effectiveness can be assessed more accurately through continuous monitoring.

Personalized Medicine

Advances in healthcare technology and genetic research are leading to more personalized treatment approaches. Tailored treatment plans that consider an individual's genetic makeup and unique health characteristics may increase the demand for medications like Losartan, which can be part of a personalized hypertension management strategy. Personalized medicine often begins with genetic profiling. By analyzing an individual's genetic makeup, healthcare providers can identify genetic variations that influence their response to medications. For Losartan, genetic testing can help determine whether a patient is more likely to respond favorably to the drug or if alternative treatments might be more appropriate. This precise approach ensures that Losartan is prescribed to those who are most likely to benefit from it, increasing demand among suitable candidates.

Personalized medicine allows for the fine-tuning of medication dosages based on genetic and individual patient data. For Losartan, this means that healthcare providers can adjust the dosage to achieve the optimal blood pressure control for each patient. Avoiding overmedication or undermedication enhances patient outcomes and reduces potential side effects, increasing patient satisfaction and demand for Losartan.

Segmental Insights

Form Insights

Based on the form, the market is segmented into tablet and powder. The demand for Losartan in tablet form is higher than that for other forms, such as powder. Tablets are easy to handle and swallow, making them a convenient choice for most patients, including the elderly and those with swallowing difficulties. Tablets are pre-measured and provide a standardized dosage, ensuring accurate and consistent medication administration. Losartan tablets are typically packaged in blister packs or bottles, making it easy to store and transport them safely. Patients and healthcare providers are generally more familiar with tablet medications, which contributes to their popularity.

Application Insights

Based on the application segment, the market is segmented into hypertension, stroke, diabetic nephropathy, and others. The hypertension segment dominated the market as Losartan is primarily used for the treatment of hypertension, which is commonly known as high blood pressure. Hypertension is a widespread health issue, affecting a substantial portion of the global population. It is estimated that over one billion people worldwide have hypertension. This high prevalence ensures a consistent and substantial demand for antihypertensive medications like Losartan. In recent years, there has been a concerted effort to raise awareness about hypertension and promote regular blood pressure monitoring. As a result, more individuals are being diagnosed with high blood pressure, leading to an increased demand for effective treatments. Hypertension tends to become more prevalent with age. As the global population ages, a larger proportion of individuals are at risk of developing hypertension, further driving the demand for antihypertensive medications.

Regional Insights

North America, including the United States and Canada, has a significant demand for antihypertensive medications like Losartan. The region has a large aging population, and hypertension is a common health issue. Increased awareness of cardiovascular health and access to healthcare services contribute to a robust demand for these medications. The United States and Canada have well-established healthcare systems and infrastructure. Access to healthcare services, including regular check-ups and diagnostic testing, is relatively widespread. This facilitates the diagnosis and management of hypertension and contributes to the demand for antihypertensive medications. There is a strong emphasis on health awareness and prevention in North America. Educational campaigns and initiatives by healthcare organizations, government agencies, and non-profit organizations promote awareness of cardiovascular risk factors, including hypertension. This heightened awareness encourages individuals to seek medical care and adhere to prescribed treatment plans, including the use of medications like Losartan.

Key Market Players

Merck & Co. Inc.

Pfizer Inc.

Teva Pharmaceutical Industries Ltd.

Sanofi S.A.

Novartis International AG

Dr. Reddy's Laboratories Ltd.

Sun Pharmaceuticals Industries Ltd.

Aurobindo Pharma Ltd.

Torrent Pharmaceutical Ltd.

Lupin Ltd.

Report Scope:

In this report, the Global Losartan Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Losartan Market, By Source:

Contract Manufacturing Organizations
In-House

Losartan Market, By Form:

Tablet
Powder

Losartan Market, By Application:

Hypertension
Stroke
Diabetic Nephropathy
Others

Losartan Market, By Region:

North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Turkey
Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Losartan Market.

Available Customizations:

Global Losartan market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Losartan Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Source (Contract Manufacturing Organizations, In-House)
- 5.2.2. By Form (Tablet, Powder)
- 5.2.3. By Application (Hypertension, Stroke, Diabetic Nephropathy, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2022)
5.3. Market Map

6. North America Losartan Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Source
- 6.2.2. By Form
- 6.2.3. By Application
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Losartan Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Source
    - 6.3.1.2.2. By Form
    - 6.3.1.2.3. By Application
- 6.3.2. Canada Losartan Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Source
    - 6.3.2.2.2. By Form
    - 6.3.2.2.3. By Application
- 6.3.3. Mexico Losartan Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Source
    - 6.3.3.2.2. By Form
    - 6.3.3.2.3. By Application

7. Europe Losartan Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Source
- 7.2.2. By Form
- 7.2.3. By Application
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Losartan Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Source
    - 7.3.1.2.2. By Form
    - 7.3.1.2.3. By Application
- 7.3.2. United Kingdom Losartan Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Source
    - 7.3.2.2.2. By Form
    - 7.3.2.2.3. By Application
- 7.3.3. Italy Losartan Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Source
    - 7.3.3.2.2. By Form
    - 7.3.3.2.3. By Application
- 7.3.4. France Losartan Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Source
    - 7.3.4.2.2. By Form
    - 7.3.4.2.3. By Application
- 7.3.5. Spain Losartan Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Source
    - 7.3.5.2.2. By Form
    - 7.3.5.2.3. By Application

8. Asia-Pacific Losartan Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Source
- 8.2.2. By Form
- 8.2.3. By Application
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Losartan Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Source
    - 8.3.1.2.2. By Form
    - 8.3.1.2.3. By Application
- 8.3.2. India Losartan Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Source
    - 8.3.2.2.2. By Form
    - 8.3.2.2.3. By Application
- 8.3.3. Japan Losartan Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Source
    - 8.3.3.2.2. By Form
    - 8.3.3.2.3. By Application
- 8.3.4. South Korea Losartan Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Source
    - 8.3.4.2.2. By Form
    - 8.3.4.2.3. By Application
- 8.3.5. Australia Losartan Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Source
    - 8.3.5.2.2. By Form
    - 8.3.5.2.3. By Application

9. South America Losartan Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Source
- 9.2.2. By Form
- 9.2.3. By Application
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Losartan Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Source
    - 9.3.1.2.2. By Form
    - 9.3.1.2.3. By Application
- 9.3.2. Argentina Losartan Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Source
    - 9.3.2.2.2. By Form
    - 9.3.2.2.3. By Application
- 9.3.3. Colombia Losartan Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Source
    - 9.3.3.2.2. By Form
    - 9.3.3.2.3. By Application

10. Middle East and Africa Losartan Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Source
- 10.2.2. By Form
- 10.2.3. By Application
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Losartan Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Source
    - 10.3.1.2.2. By Form
    - 10.3.1.2.3. By Application
- 10.3.2. Saudi Arabia Losartan Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Source
    - 10.3.2.2.2. By Form
    - 10.3.2.2.3. By Application
- 10.3.3. UAE Losartan Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Source
    - 10.3.3.2.2. By Form
    - 10.3.3.2.3. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Global Losartan Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Business Overview
15.2. Service Offerings
15.3. Recent Developments
15.4. Key Personnel
15.5. SWOT Analysis
- 15.5.1. Merck & Co. Inc.
- 15.5.2. Pfizer Inc.
- 15.5.3. Teva Pharmaceutical Industries Ltd.
- 15.5.4. Sanofi S.A.
- 15.5.5. Novartis International AG
- 15.5.6. Dr. Reddy's Laboratories Ltd.
- 15.5.7. Sun Pharmaceuticals Industries Ltd.
- 15.5.8. Aurobindo Pharma Ltd.
- 15.5.9. Torrent Pharmaceutical Ltd.
- 15.5.10. Lupin Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer

02-2729-4219

+886-2-2729-4219

License/价格

洛沙坦市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按来源、形式、按应用、地区和竞争细分

Losartan Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Source, By Form, By Application, By Region and Competition

主要市场驱动因素

高血压盛行率不断上升

老年人口增加

提高临床疗效

专利到期和仿製药竞争

主要市场挑战

副作用和耐受性

替代药物

主要市场趋势

远距医疗和远端监控

个人化医疗

细分市场洞察

形成洞察

应用洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球氯沙坦市场展望

第 6 章：北美氯沙坦市场展望

第 7 章：欧洲氯沙坦市场展望

第 8 章：亚太地区氯沙坦市场展望

第 9 章：南美洲氯沙坦市场展望

第 10 章：中东和非洲氯沙坦市场展望

第 11 章：市场动态

第 12 章：市场趋势与发展

第 13 章：全球氯沙坦市场：SWOT 分析

第 14 章：波特的五力分析

第15章：竞争格局

第 16 章：策略建议

第 17 章：关于我们与免责声明

Key Market Drivers

Growing Prevalence of Hypertension

Rising Geriatric Population

Increasing Clinical Efficacy

Patent Expiration and Generic Competition

Key Market Challenges

Side Effects and Tolerability

Alternative Medications

Key Market Trends

Telehealth and Remote Monitoring

Personalized Medicine

Segmental Insights

Form Insights

Application Insights

Regional Insights

Key Market Players

Report Scope:

Losartan Market, By Source:

Losartan Market, By Form:

Losartan Market, By Application:

Losartan Market, By Region:

Competitive Landscape

Available Customizations:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Losartan Market Outlook

6. North America Losartan Market Outlook

7. Europe Losartan Market Outlook

8. Asia-Pacific Losartan Market Outlook

9. South America Losartan Market Outlook

10. Middle East and Africa Losartan Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Losartan Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. About Us & Disclaimer